Skip to main content

Principal Healthcare Innovators ETF

Open-end / ETF
Registrant
Principal Exchange-Traded Funds
Net Assets
$16,442,837
Holdings
268
Latest Report
Jun 30, 2024

Net Assets Over Time

Holdings · 268

Export CSV
Showing 1–50 of 268 holdings by value · page 1 of 6
Holding Balance Value % of Fund Open
Catalent Inc
6,413 $360,603 2.19%
Roivant Sciences Ltd
28,688 $303,232 1.84%
Exact Sciences Corp
6,432 $271,752 1.65%
Cerevel Therapeutics Holdings Inc
6,422 $262,596 1.60%
Blueprint Medicines Corp
2,196 $236,685 1.44%
Intra-Cellular Therapies Inc
3,432 $235,058 1.43%
Apellis Pharmaceuticals Inc
4,272 $163,874 1.00%
Nuvalent Inc
2,103 $159,534 0.97%
Crinetics Pharmaceuticals Inc
2,819 $126,263 0.77%
Avidity Biosciences Inc
3,004 $122,713 0.75%
Amicus Therapeutics Inc
10,711 $106,253 0.65%
Arcellx Inc
1,909 $105,358 0.64%
Inari Medical Inc
2,148 $103,426 0.63%
Biohaven Ltd
2,937 $101,943 0.62%
SpringWorks Therapeutics Inc
2,667 $100,466 0.61%

Showing the top 50 of 268 holdings. Create a free account to see every holding and download the CSV.